| Year |
Citation |
Score |
| 2019 |
Cui H, Esworthy T, Zhou X, Hann SY, Glazer RI, Li R, Zhang LG. Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone. Advanced Healthcare Materials. e1900924. PMID 31846231 DOI: 10.1002/Adhm.201900924 |
0.333 |
|
| 2018 |
Yuan H, Wang X, Shi C, Jin L, Hu J, Zhang A, Li J, Vijayendra N, Doodala V, Weiss S, Tang Y, Weiner LM, Glazer RI. Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis. Scientific Reports. 8: 5717. PMID 29632317 DOI: 10.1038/S41598-018-24022-W |
0.421 |
|
| 2018 |
Yuan H, Wang X, Lu J, Zhang Q, Brandina I, Alexandrov I, Glazer RI. MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment. Oncotarget. 9: 8042-8053. PMID 29487713 DOI: 10.18632/Oncotarget.24233 |
0.415 |
|
| 2018 |
Yuan H, Chen V, Boisvert M, Isaacs C, Glazer RI. PLAC1 as a serum biomarker for breast cancer. Plos One. 13: e0192106. PMID 29432428 DOI: 10.1371/Journal.Pone.0192106 |
0.308 |
|
| 2017 |
Glazer RI, Kopelovich L. PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer. Oncotarget. 8: 50337-50341. PMID 28881566 DOI: 10.18632/Oncotarget.17302 |
0.304 |
|
| 2017 |
Glazer RI, Yuan H, Jin L. Abstract 5892: Induction of stromal fibrosis accelerates tumorigenesis in NeuT mice Cancer Research. 77: 5892-5892. DOI: 10.1158/1538-7445.Am2017-5892 |
0.306 |
|
| 2016 |
Glazer RI. PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance. Ppar Research. 2016: 3082340. PMID 28077942 DOI: 10.1155/2016/3082340 |
0.304 |
|
| 2016 |
Zhou X, Zhu W, Nowicki M, Miao S, Cui H, Holmes B, Glazer RI, Zhang LG. 3D Bioprinting a Cell-laden Bone Matrix for Breast Cancer Metastasis Study. Acs Applied Materials & Interfaces. PMID 27766838 DOI: 10.1021/Acsami.6B10673 |
0.334 |
|
| 2016 |
Zhu W, Castro NJ, Cui H, Zhou X, Boualam B, McGrane R, Glazer RI, Zhang LG. A 3D printed nano bone matrix for characterization of breast cancer cell and osteoblast interactions. Nanotechnology. 27: 315103. PMID 27346678 DOI: 10.1088/0957-4484/27/31/315103 |
0.306 |
|
| 2015 |
Ligaba SB, Khurana A, Graham G, Krawczyk E, Jablonski S, Petricoin EF, Glazer RI, Upadhyay G. Multifactorial analysis of conditional reprogramming of human keratinocytes. Plos One. 10: e0116755. PMID 25714835 DOI: 10.1371/Journal.Pone.0116755 |
0.391 |
|
| 2015 |
Yuan H, Glazer R, Wang X, Jin L, Li J, Vijayendra N, Doodala V, Weiss S. Placental protein-1 (plac1) modulates immune tolerance in mammary tumor cells Journal For Immunotherapy of Cancer. 3: P221. DOI: 10.1186/2051-1426-3-S2-P221 |
0.424 |
|
| 2013 |
Yuan H, Lu J, Xiao J, Upadhyay G, Umans R, Kallakury B, Yin Y, Fant ME, Kopelovich L, Glazer RI. PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation. Cancer Research. 73: 4349-61. PMID 23811944 DOI: 10.1158/0008-5472.Can-13-0322 |
0.374 |
|
| 2013 |
Wang XY, Yu H, Linnoila RI, Li L, Li D, Mo B, Okano H, Penalva LO, Glazer RI. Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer. Oncotarget. 4: 739-50. PMID 23715514 DOI: 10.18632/Oncotarget.1034 |
0.331 |
|
| 2013 |
Dabydeen SA, Wang W, Diaz-Cruz ES, Kopelovich L, Glazer RI, Furth PA. Abstract 197: Reduction in lobular but not ductal hyperplasia by the PGR inhibitor ORG33628 in a CYP19A1 overexpressing mouse model of breast cancer risk. Cancer Research. 73: 197-197. DOI: 10.1158/1538-7445.Am2013-197 |
0.399 |
|
| 2013 |
Glazer RI, Yuan H, Upadhyay G, Yin Y, Kopelovich L. Abstract 1385: PPARδ promotes mammary tumorigenesis through mTOR activation. Cancer Research. 73: 1385-1385. DOI: 10.1158/1538-7445.Am2013-1385 |
0.421 |
|
| 2012 |
Yuan H, Kopelovich L, Yin Y, Lu J, Glazer RI. Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy. Oncotarget. 3: 345-56. PMID 22538444 DOI: 10.18632/Oncotarget.457 |
0.391 |
|
| 2012 |
Yuan H, Upadhyay G, Lu J, Kopelovich L, Glazer RI. The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature. Cancer Prevention Research (Philadelphia, Pa.). 5: 754-64. PMID 22427346 DOI: 10.1158/1940-6207.Capr-11-0526 |
0.37 |
|
| 2012 |
Glazer RI, Vo DT, Penalva LOF. Musashi1: An RBP with versatile functions in normal and cancer stem cells Frontiers in Bioscience. 17: 54-64. PMID 22201732 DOI: 10.2741/3915 |
0.415 |
|
| 2012 |
Yuan H, Upadhyay G, Yin Y, Kopelovich L, Glazer RI. Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator-activated receptorγ activation. Cancer Prevention Research (Philadelphia, Pa.). 5: 51-60. PMID 21955520 DOI: 10.1158/1940-6207.Capr-11-0256 |
0.43 |
|
| 2012 |
Borellini F, Glazer R, Kopelovich L. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus is accompanied by nuclear accumulation of the tumor suppressor p53. International Journal of Oncology. 8: 609-15. PMID 21544404 DOI: 10.3892/Ijo.8.3.609 |
0.361 |
|
| 2011 |
Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM, Brown ML, Toretsky JA, Uren A, Lee Y, MacDonald TJ, Rodriguez O, Glazer RI, Schlegel R, Albanese C. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biology & Therapy. 12: 818-26. PMID 21885916 DOI: 10.4161/Cbt.12.9.17682 |
0.388 |
|
| 2011 |
Upadhyay G, Yin Y, Yuan H, Li X, Derynck R, Glazer RI. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proceedings of the National Academy of Sciences of the United States of America. 108: 7820-5. PMID 21518866 DOI: 10.1073/Pnas.1103441108 |
0.403 |
|
| 2011 |
Pollock CB, Yin Y, Yuan H, Zeng X, King S, Li X, Kopelovich L, Albanese C, Glazer RI. PPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis. Plos One. 6: e16215. PMID 21297860 DOI: 10.1371/Journal.Pone.0016215 |
0.448 |
|
| 2010 |
Pollock CB, Rodriguez O, Martin PL, Albanese C, Li X, Kopelovich L, Glazer RI. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. Ppar Research. 2010: 571783. PMID 21318167 DOI: 10.1155/2010/571783 |
0.36 |
|
| 2010 |
Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H, Glazer RI. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Molecular Cancer. 9: 221. PMID 20727204 DOI: 10.1186/1476-4598-9-221 |
0.403 |
|
| 2010 |
Yuan H, Upadhyay G, Yin Y, Pollock C, Kopelovich L, Glazer RI. Abstract 945: Sca-1 deficiency enhances the chemopreventive activity of a peroxisome proliferator-activated receptorγ (PPARγ) agonist Cancer Research. 70: 945-945. DOI: 10.1158/1538-7445.Am10-945 |
0.455 |
|
| 2010 |
Upadhyay G, Pollock C, Yin Y, Yuan H, Kopelovich L, Glazer RI. Abstract 4214: Stem cell antigen-1 (Sca1) modulates PI3K/PTEN signaling and mammary tumor cell survival Cancer Research. 70: 4214-4214. DOI: 10.1158/1538-7445.Am10-4214 |
0.443 |
|
| 2010 |
Pollock CB, Yin Y, Yuan H, Zeng X, King S, Kopelovich L, Glazer RI. Abstract 3263: Acceleration of mammary tumorigenesis by PDK1 and peroxisome proliferator-activated receptorδ Cancer Research. 70: 3263-3263. DOI: 10.1158/1538-7445.Am10-3263 |
0.449 |
|
| 2009 |
Li S, Zhang D, Yang L, Burnier JV, Wang N, Lin R, Lee ER, Glazer RI, Brodt P. The IGF-I receptor can alter the matrix metalloproteinase repertoire of tumor cells through transcriptional regulation of PKC-{alpha}. Molecular Endocrinology (Baltimore, Md.). 23: 2013-25. PMID 19855090 DOI: 10.1210/Me.2009-0197 |
0.393 |
|
| 2009 |
Rodriguez OC, Lai EW, Vissapragada S, Cromelin C, Avetian M, Salinas P, Ramos H, Kallakury B, Casimiro M, Lisanti MP, Tanowitz HB, Pacak K, Glazer RI, Avantaggiati M, Albanese C. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. The American Journal of Pathology. 174: 2051-60. PMID 19443706 DOI: 10.2353/Ajpath.2009.080859 |
0.366 |
|
| 2009 |
Wang X, Zhao J, Tang S, Lee S, Glazer RI, Hewlett I. c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells. Molecular and Cellular Biochemistry. 330: 23-9. PMID 19363595 DOI: 10.1007/S11010-009-0096-3 |
0.331 |
|
| 2009 |
Yin Y, Yuan H, Zeng X, Kopelovich L, Glazer RI. Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification. Cancer Research. 69: 687-94. PMID 19147585 DOI: 10.1158/0008-5472.Can-08-2446 |
0.431 |
|
| 2008 |
Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C, Katiyar S, Rao M, Allen KG, Glazer RI, Ge C, et al. ErbB2 induces Notch1 activity and function in breast cancer cells. Clinical and Translational Science. 1: 107-15. PMID 20443831 DOI: 10.1111/J.1752-8062.2008.00041.X |
0.382 |
|
| 2008 |
Glazer RI, Wang XY, Yuan H, Yin Y. Musashi1: a stem cell marker no longer in search of a function. Cell Cycle (Georgetown, Tex.). 7: 2635-9. PMID 18719393 DOI: 10.4161/Cc.7.17.6522 |
0.384 |
|
| 2008 |
Glazer RI, Yuan H, Xie Z, Yin Y. PPARgamma and PPARdelta as Modulators of Neoplasia and Cell Fate. Ppar Research. 2008: 247379. PMID 18566686 DOI: 10.1155/2008/247379 |
0.358 |
|
| 2008 |
Wang XY, Yin Y, Yuan H, Sakamaki T, Okano H, Glazer RI. Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Molecular and Cellular Biology. 28: 3589-99. PMID 18362162 DOI: 10.1128/Mcb.00040-08 |
0.435 |
|
| 2007 |
Glazer RI, Wang X, Yuan H, Yin Y. Mammary stem and progenitor cell regulation. Cancer Biomarkers : Section a of Disease Markers. 3: 171-81. PMID 17917147 DOI: 10.3233/Cbm-2007-34-502 |
0.321 |
|
| 2007 |
Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, ... Glazer RI, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biology. 8: R76. PMID 17493263 DOI: 10.1186/Gb-2007-8-5-R76 |
0.34 |
|
| 2006 |
Liang K, Lu Y, Li X, Zeng X, Glazer RI, Mills GB, Fan Z. Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine. Molecular Pharmacology. 70: 1045-52. PMID 16782806 DOI: 10.1124/Mol.106.023333 |
0.453 |
|
| 2006 |
Xie Z, Yuan H, Yin Y, Zeng X, Bai R, Glazer RI. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. Bmc Cancer. 6: 77. PMID 16551362 DOI: 10.1186/1471-2407-6-77 |
0.374 |
|
| 2006 |
Koller E, Propp S, Zhang H, Zhao C, Xiao X, Chang M, Hirsch SA, Shepard PJ, Koo S, Murphy C, Glazer RI, Dean NM. Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development Cancer Research. 66: 2059-2066. PMID 16489005 DOI: 10.1158/0008-5472.Can-05-1531 |
0.42 |
|
| 2006 |
Yin Y, Yuan H, Wang C, Pattabiraman N, Rao M, Pestell RG, Glazer RI. 3-Phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor- and promotes adipocyte differentiation Molecular Endocrinology. 20: 268-278. PMID 16150867 DOI: 10.1210/Me.2005-0197 |
0.402 |
|
| 2005 |
Yin Y, Bai R, Russell RG, Beildeck ME, Xie Z, Kopelovich L, Glazer RI. Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling. Molecular Carcinogenesis. 44: 42-50. PMID 15937957 DOI: 10.1002/Mc.20119 |
0.34 |
|
| 2005 |
Yin Y, Russell RG, Dettin LE, Bai R, Wei ZL, Kozikowski AP, Kopelovich L, Kopleovich L, Glazer RI. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Cancer Research. 65: 3950-7. PMID 15867396 DOI: 10.1158/0008-5472.Can-04-3990 |
0.402 |
|
| 2005 |
Zhan M, Yu D, Liu J, Glazer RI, Hannay J, Pollock RE. Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation. The Journal of Biological Chemistry. 280: 4825-33. PMID 15563462 DOI: 10.1074/Jbc.M407450200 |
0.308 |
|
| 2004 |
Wei ZL, Petukhov PA, Bizik F, Teixeira JC, Mercola M, Volpe EA, Glazer RI, Willson TM, Kozikowski AP. Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation. Journal of the American Chemical Society. 126: 16714-5. PMID 15612696 DOI: 10.1021/Ja046386L |
0.315 |
|
| 2003 |
Xie Z, Zeng X, Waldman T, Glazer RI. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1. Cancer Research. 63: 5370-5. PMID 14500370 |
0.358 |
|
| 2002 |
Clark JH, Haridasse V, Glazer RI. Modulation of the human protein kinase C alpha gene promoter by activator protein-2. Biochemistry. 41: 11847-56. PMID 12269829 DOI: 10.1021/Bi025600K |
0.633 |
|
| 2002 |
Zeng X, Xu H, Glazer RI. Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha. Cancer Research. 62: 3538-43. PMID 12068001 |
0.373 |
|
| 2002 |
Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI. Delayed mammary gland involution in MMTV-AKT1 transgenic mice. Oncogene. 21: 198-206. PMID 11803463 DOI: 10.1038/Sj.Onc.1205052 |
0.704 |
|
| 2001 |
Rohlff C, Glazer RI. Regulation of the MDR1 promoter by cyclic AMP-dependent protein kinase and transcription factor Sp1. International Journal of Oncology. 12: 383-6. PMID 9458366 DOI: 10.3892/Ijo.12.2.383 |
0.393 |
|
| 1999 |
Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 18: 4440-9. PMID 10442635 DOI: 10.1038/Sj.Onc.1202827 |
0.33 |
|
| 1999 |
Ahmad S, Singh N, Glazer RI. Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochemical Pharmacology. 58: 425-30. PMID 10424760 DOI: 10.1016/S0006-2952(99)00125-2 |
0.426 |
|
| 1999 |
Shen L, Dean NM, Glazer RI. Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase Calpha antisense oligonucleotide. Molecular Pharmacology. 55: 396-402. PMID 9927633 DOI: 10.1124/Mol.55.2.396 |
0.399 |
|
| 1998 |
Shen L, Glazer RI. Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1-binding protein-3. Biochemical Pharmacology. 55: 1711-9. PMID 9634008 DOI: 10.1016/S0006-2952(98)00045-8 |
0.395 |
|
| 1997 |
Rohlff C, Ahmad S, Borellini F, Lei J, Glazer RI. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. The Journal of Biological Chemistry. 272: 21137-41. PMID 9261118 DOI: 10.1074/Jbc.272.34.21137 |
0.356 |
|
| 1997 |
Glazer RI. Protein kinase C as a target for cancer therapy. Antisense & Nucleic Acid Drug Development. 7: 235-8. PMID 9212917 DOI: 10.1089/Oli.1.1997.7.235 |
0.309 |
|
| 1997 |
Kozikowski AP, Wang S, Ma D, Yao J, Ahmad S, Glazer RI, Bogi K, Acs P, Modarres S, Lewin NE, Blumberg PM. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity. Journal of Medicinal Chemistry. 40: 1316-26. PMID 9135029 DOI: 10.1021/Jm960875H |
0.352 |
|
| 1996 |
He Y, Borellini F, Koch WH, Huang KX, Glazer RI. Transcriptional regulation of c-Fes in myeloid leukemia cells. Biochimica Et Biophysica Acta. 1306: 179-86. PMID 8634335 DOI: 10.1016/0167-4781(96)00005-X |
0.356 |
|
| 1996 |
Rohlff C, Glazer RI. Regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cellular Signalling. 7: 431-43. PMID 8562304 DOI: 10.1016/0898-6568(95)00018-K |
0.371 |
|
| 1995 |
Glazer RI, Rohlff C. Transcriptional regulation of multidrug resistance in breast cancer. Breast Cancer Research and Treatment. 31: 263-71. PMID 7881104 DOI: 10.1007/Bf00666159 |
0.386 |
|
| 1995 |
Yu G, Shen FS, Sturch S, Aquino A, Glazer RI, Felsted RL. Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. The Journal of Biological Chemistry. 270: 4792-6. PMID 7876252 DOI: 10.1074/Jbc.270.9.4792 |
0.351 |
|
| 1994 |
Ahmad S, Safa AR, Glazer RI. Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system. Biochemistry. 33: 10313-8. PMID 7915139 DOI: 10.1021/Bi00200A011 |
0.304 |
|
| 1994 |
Ahmad S, Mineta T, Martuza RL, Glazer RI. Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery. 35: 904-8; discussion 90. PMID 7838340 DOI: 10.1227/00006123-199411000-00015 |
0.372 |
|
| 1993 |
Fang F, Ahmad S, Lei J, Klecker RW, Trepel JB, Smithgall TE, Glazer RI. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells. Biochemistry. 32: 6995-7001. PMID 8334128 DOI: 10.1021/Bi00078A026 |
0.33 |
|
| 1993 |
Rahman A, Husain SR, Siddiqui J, Verma M, Agresti M, Center M, Safa AR, Glazer RI. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells. Journal of the National Cancer Institute. 84: 1909-15. PMID 1361008 DOI: 10.1093/Jnci/84.24.1909 |
0.341 |
|
| 1992 |
Smithgall TE, Goswami BB, Nagashfar Z, Ahmad S, Glazer RI. Construction of a cDNA for the human c-fes protooncogene protein-tyrosine kinase and its expression in a baculovirus system. Biochemistry. 31: 4828-33. PMID 1591243 DOI: 10.1021/Bi00135A013 |
0.3 |
|
| 1991 |
Burke TR, Li ZH, Bolen JB, Chapekar M, Gang Y, Glazer RI, Rice KC, Marquez VE. Examination of the possible mediation of antineoplastic effects of opiates through the inhibition of tyrosine-specific protein kinases. Biochemical Pharmacology. 41: R17-20. PMID 2018548 DOI: 10.1016/0006-2952(91)90554-I |
0.346 |
|
| 1991 |
Smithgall TE, Johnston JB, Bustin M, Glazer RI. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification. Journal of the National Cancer Institute. 83: 42-6. PMID 1984516 DOI: 10.1093/Jnci/83.1.42 |
0.305 |
|
| 1991 |
Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Cowan KH, Glazer RI. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Communications. 3: 181-9. PMID 1675575 DOI: 10.3727/095535491820873263 |
0.37 |
|
| 1990 |
Aquino A, Warren BS, Omichinski J, Hartman KD, Glazer RI. Protein kinase C-gamma is present in adriamycin resistant HL-60 leukemia cells. Biochemical and Biophysical Research Communications. 166: 723-8. PMID 2302237 DOI: 10.1016/0006-291X(90)90869-O |
0.369 |
|
| 1990 |
Borellini F, Aquino A, Josephs SF, Glazer RI. Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells Molecular and Cellular Biology. 10: 5541-5547. PMID 2204818 DOI: 10.1128/Mcb.10.10.5541 |
0.344 |
|
| 1990 |
Aquino A, Johnson-Thompson M, Glazer RI. Enhanced Ca2+ -dependent proteolysis associated with Adriamycin®-resistant HL-60 cells Cancer Communications. 2: 243-247. PMID 2198910 DOI: 10.3727/095535490820874335 |
0.38 |
|
| 1988 |
Chapekar MS, Glazer RI. The synergistic cytocidal effect produced by immune interferon and tumor necrosis factor in HT-29 cells is associated with inhibition of rRNA processing and (2',5') oligo (A) activation of RNase L. Biochemical and Biophysical Research Communications. 151: 1180-7. PMID 2451518 DOI: 10.1016/S0006-291X(88)80490-X |
0.328 |
|
| 1987 |
Glazer RI, Knode MC, Tseng CK, Haines DR, Marquez VE. 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochemical Pharmacology. 35: 4523-7. PMID 3790170 DOI: 10.1016/0006-2952(86)90774-4 |
0.324 |
|
| 1987 |
Zylber-Katz E, Knode MC, Glazer RI. Retinoic acid promotes phorbol ester-initiated macrophage differentiation in HL-60 leukemia cells without disappearance of protein kinase C. Leukemia Research. 10: 1425-32. PMID 3099098 DOI: 10.1016/0145-2126(86)90009-3 |
0.342 |
|
| 1986 |
Glazer RI, Cohen MB, Hartman KD, Knode MC, Lim MI, Marquez VE. Induction of differentiation in the human promyelocytic leukemia cell line HL-60 by the cyclopentenyl analogue of cytidine. Biochemical Pharmacology. 35: 1841-8. PMID 3459463 DOI: 10.1016/0006-2952(86)90301-1 |
0.343 |
|
| 1986 |
Glazer RI, Hartman KD, Knode MC, Richard MM, Chiang PK, Tseng CK, Marquez VE. 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochemical and Biophysical Research Communications. 135: 688-94. PMID 3457563 DOI: 10.1016/0006-291X(86)90048-3 |
0.332 |
|
| 1986 |
Glazer RI, Chapekar MS, Hartman KD, Knode MC. Appearance of membrane-bound tyrosine kinase during differentiation of HL-60 leukemia cells by immune interferon and tumor necrosis factor. Biochemical and Biophysical Research Communications. 140: 905-15. PMID 3096330 DOI: 10.1016/0006-291X(86)90721-7 |
0.348 |
|
| 1985 |
Chapekar MS, Bustin M, Glazer RI. Evidence that high mobility group protein 17 is not phosphorylated in human colon carcinoma cells. Biochimica Et Biophysica Acta. 838: 351-4. PMID 3882153 DOI: 10.1016/0304-4165(85)90233-8 |
0.356 |
|
| 1982 |
Ritch PS, Glazer RI. Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro. Biochemical Pharmacology. 31: 259-61. PMID 7059368 DOI: 10.1016/0006-2952(82)90222-2 |
0.3 |
|
| 1982 |
Jayaram HN, Dion RL, Glazer RI, Johns DG, Robins RK, Srivastava PC, Cooney DA. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193). Biochemical Pharmacology. 31: 2371-80. PMID 6127085 DOI: 10.1016/0006-2952(82)90532-9 |
0.32 |
|
| 1980 |
Glazer RI, Peale AL. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro. Biochemical Pharmacology. 29: 305-10. PMID 7362643 DOI: 10.1016/0006-2952(80)90505-5 |
0.303 |
|
| 1978 |
Legraverend M, Glazer RI. Inhibition of the phosphorylation of nonhistone chromosomal proteins by cordycepin and xylosyladenine in L1210 cells in vitro. Molecular Pharmacology. 14: 1130-1135. DOI: 10.1016/B978-0-08-023768-8.50181-X |
0.353 |
|
| Show low-probability matches. |